NCT07892261

Brief Summary

The goal of this clinical trial is to investigate the effect of local application of levofloxacin gel on healing of periodontal pockets in patients with stage II/III periodontitis. The main questions it aims to answer are:

  • Undergo professional mechanical plaque removal (PMPR) then will be injected with the in-situ gel in selected pockets.
  • Be given strict oral hygiene instructions to follow at home after the application of gel.
  • Come back for reapplication of the gel a week later.
  • Visit the clinic at selected follow-up periods: after 1 month, 3 months, and 6 months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 3, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 19, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 4, 2025

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

October 18, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 23, 2026

Completed
Last Updated

October 23, 2026

Status Verified

October 1, 2026

Enrollment Period

1 year

First QC Date

October 18, 2026

Last Update Submit

October 18, 2026

Conditions

Outcome Measures

Primary Outcomes (5)

  • Probing depth

    To assess changes in probing depth using William's probe, measuring it from the base of the pocket up to the gingival margin. A decrease in probing depth readings indicates improved clinical outcomes.

    Up to 6 months.

  • Clinical Attachment Loss

    To assess changes in clinical attachment loss using William's probe, measured from the base of the pocket up to the gingival margin, then the distance between cemento-enamel junction to the gingival margin is measured. The second measurement is then deducted from the first one to calculate clinical attachment loss. During follow-up, a decrease in this figure represents gain in attachment, hence healing.

    Up to 6 months

  • Modified Gingival Index

    Using a scale from 0 to 4, visual assessment is used to grade the gingival index, with a score of 0 representing normal gingiva, up to a score of 4 representing the most inflammed tissue.

    Up to 6 months

  • Bleeding Index

    A scale from 0 to 3 is used to grade bleeding index. Using a probe, you gently pass along the gingival margin to check the presence and grade of bleeding. 0 represents no bleeding, 3 represents profuse bleeding in the intended area.

    Up to 6 months

  • O'leary Plaque Index

    It's graded by a scale ranging from 0 to 3, with 0 representing no plaque and 3 representing heavy plaque seen by the naked eye. William's probe is used to gently move in a brushing motion along the gingival margin to detect any plaque.

    Up to 6 months

Study Arms (2)

With gel

EXPERIMENTAL

PMPR then application of levofloxacin in-situ gel in pockets of patients with stage II and III periodontitis and follow-up at 1 month, 3 months, and 6 months.

Drug: Levofloxacin in-situ gelProcedure: Professional mechanical plaque removal

Without gel

ACTIVE COMPARATOR

PMPR only then follow-up at 1 month, 3 months, and 6 months.

Procedure: Professional mechanical plaque removal

Interventions

Topically applied levofloxacin in-situ gel in selected pockets of patients with stage II and III periodontitis

With gel

Thorough mechanical debridement of pockets and gingival structure

With gelWithout gel

Eligibility Criteria

Age30 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age limit of 30-65 years of both the genders.
  • Probing pocket depth (PPD) of ≥5mm (stage II/III) bilaterally.
  • Systemically healthy subjects.
  • No history of periodontal therapy within 6 months prior to the study.

You may not qualify if:

  • \. Chronic use of antibiotics/ anti- inflammatory drugs 3 months prior to the study 2. Routine use of mouthwash or other plaque controlling agents 3. Diabetic patients or other immunocompromised patients 4. Any form of tobacco users, alcohol users. 5. Known history of allergy to drugs 6. Pregnant and lactating women. 7. Pathologic migration / tooth under traumatic occlusion.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry, Alexandria University

Alexandria, Alexandria Governorate, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MSc candidate in periodontology

Study Record Dates

First Submitted

October 18, 2026

First Posted

October 23, 2026

Study Start

August 3, 2024

Primary Completion

August 19, 2025

Study Completion

October 4, 2025

Last Updated

October 23, 2026

Record last verified: 2026-10

Locations